Evolent Health (NYSE:EVH) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $0.09 by 214.94 percent. This is a 133.33 percent decrease over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $444.328 million which missed the analyst consensus estimate of $459.430 million by 3.29 percent. This is a 31.34 percent decrease over sales of $647.145 million the same period last year.